20 Mar 2018

London, 20 March 2018 - Mereo BioPharma Group plc (AIM: MPH) (the "Company"), a multi-asset  biopharmaceutical company focused on rare and specialty diseases, confirms that an explanatory circular (the "Circular"), which incorporates a notice convening a general meeting (the "Notice of General Meeting"), and a form of proxy will be posted to shareholders today.

 

CLICK HERE TO VIEW THE NOTICE OF GENERAL MEETING